7 Einträge gefunden

1. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis

   1. Simpson, Eric L
   2. Bissonnette, Robert
   3. Paller, Amy S
   4. King, Brett
   5. Silverberg, Jonathan I
   6. Reich, Kristian
   7. Thyssen, Jacob P

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis

   1. Reich, Kristian
   2. Lio, Peter A
   3. Bissonnette, Robert
   4. Alexis, Andrew F
   5. Lebwohl, Mark G
   6. Pink, Andrew E
   7. Kabashima, Kenji

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials

   1. Silverberg, Jonathan I
   2. Simpson, Eric L
   3. Wollenberg, Andreas
   4. Bissonnette, Robert
   5. Kabashima, Kenji
   6. DeLozier, Amy M
   7. Sun, Luna

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

   1. Mrowietz, Ulrich
   2. Burden, A David
   3. Pinter, Andreas
   4. Reich, Kristian
   5. Schäkel, Knut
   6. Baum, Patrick
   7. Datsenko, Yakov

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab

   1. Mehta, Heena
   2. Mashiko, Shunya
   3. Angsana, Julianty
   4. Rubio, Manuel
   5. Hsieh, Ya-Ching M
   6. Maari, Catherine
   7. Reich, Kristian

   2021 - Forschungsinformationssystem des UKE
6. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

   1. Simpson, Eric
   2. Bissonnette, Robert
   3. Eichenfield, Lawrence F
   4. Guttman-Yassky, Emma
   5. King, Brett
   6. Silverberg, Jonathan I
   7. Beck, Lisa A

   2020 - Forschungsinformationssystem des UKE
7. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

   1. Deleuran, Mette
   2. Thaçi, Diamant
   3. Beck, Lisa A
   4. de Bruin-Weller, Marjolein
   5. Blauvelt, Andrew
   6. Forman, Seth
   7. Bissonnette, Robert

   2020 - Forschungsinformationssystem des UKE